rs17091403
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_018017.4(CCDC186):c.-193G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.077 in 470,688 control chromosomes in the GnomAD database, including 1,737 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.075 ( 514 hom., cov: 33)
Exomes 𝑓: 0.078 ( 1223 hom. )
Consequence
CCDC186
NM_018017.4 5_prime_UTR
NM_018017.4 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.161
Publications
26 publications found
Genes affected
CCDC186 (HGNC:24349): (coiled-coil domain containing 186) Predicted to enable small GTPase binding activity. Predicted to be involved in vesicle cytoskeletal trafficking. Predicted to act upstream of or within insulin secretion involved in cellular response to glucose stimulus and response to bacterium. Predicted to be located in Golgi apparatus. Predicted to be active in trans-Golgi network. [provided by Alliance of Genome Resources, Apr 2022]
MIR2110 (HGNC:37071): (microRNA 2110) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.016).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0997 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0751 AC: 11437AN: 152220Hom.: 514 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
11437
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0667 AC: 10136AN: 152078 AF XY: 0.0666 show subpopulations
GnomAD2 exomes
AF:
AC:
10136
AN:
152078
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0779 AC: 24811AN: 318350Hom.: 1223 Cov.: 0 AF XY: 0.0755 AC XY: 13567AN XY: 179766 show subpopulations
GnomAD4 exome
AF:
AC:
24811
AN:
318350
Hom.:
Cov.:
0
AF XY:
AC XY:
13567
AN XY:
179766
show subpopulations
African (AFR)
AF:
AC:
446
AN:
8616
American (AMR)
AF:
AC:
945
AN:
27098
Ashkenazi Jewish (ASJ)
AF:
AC:
425
AN:
10624
East Asian (EAS)
AF:
AC:
0
AN:
9188
South Asian (SAS)
AF:
AC:
2488
AN:
59592
European-Finnish (FIN)
AF:
AC:
3135
AN:
28064
Middle Eastern (MID)
AF:
AC:
61
AN:
2762
European-Non Finnish (NFE)
AF:
AC:
16279
AN:
158156
Other (OTH)
AF:
AC:
1032
AN:
14250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1284
2567
3851
5134
6418
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0750 AC: 11432AN: 152338Hom.: 514 Cov.: 33 AF XY: 0.0731 AC XY: 5446AN XY: 74500 show subpopulations
GnomAD4 genome
AF:
AC:
11432
AN:
152338
Hom.:
Cov.:
33
AF XY:
AC XY:
5446
AN XY:
74500
show subpopulations
African (AFR)
AF:
AC:
2077
AN:
41584
American (AMR)
AF:
AC:
680
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
142
AN:
3468
East Asian (EAS)
AF:
AC:
2
AN:
5188
South Asian (SAS)
AF:
AC:
185
AN:
4832
European-Finnish (FIN)
AF:
AC:
1167
AN:
10618
Middle Eastern (MID)
AF:
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6917
AN:
68016
Other (OTH)
AF:
AC:
128
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
559
1118
1678
2237
2796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
67
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.